PUNE, India, July 21, 2017 /PRNewswire/ --
According to a new market research report "Vascular Access Device Market by Type [Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories], Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022", published by MarketsandMarkets™, the Global Vascular Access Devices Market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%.
Browse 69 Market Data Tables and 40 Figures spread through 138 Pages and in-depth TOC on "Vascular Access Device Market"
Early buyers will receive 10% customization on this report
Growth in this market can be attributed to factors such as the growing prevalence of lifestyle diseases, rising number of chemotherapy procedures and increasing use of vascular access devices in pediatric patients.
The central vascular access device segment to hold the largest share of the market in 2017
By type, the market segment is segmented into central vascular access devices, peripheral vascular access devices, and accessories. Central vascular access devices are expected to account for the largest share of the market in 2017. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=122149686
By end user, hospitals are expected to hold largest market share in 2017
Based on the end users, the market is segmented into hospitals, clinics and ambulatory care centers, and other end users. In 2017, the hospital segment is expected to dominate this market. The large share of this segment can be attributed to the fact that a majority of vascular procedures are performed in hospital settings.
By application, the drug administration segment is expected to dominate the market in 2017
Based on application, the market is broadly classified into drug administration, fluids and nutrition administration, blood transfusion, and diagnostics and testing. The drug administration segment is estimated to account for the largest share of the market in 2017, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=122149686
North America to hold the largest share of the market in 2017
North American segment is expected to account the largest share of the Vascular Access Devices Market in 2017. Market growth in this region is primarily driven by factors such as the high prevalence of cardiovascular diseases; increasing number of research studies and clinical trials for vascular access devices in the U.S.; and the increase in chemotherapy procedures. Moreover, the increasing number of cardiac arrest cases, an increase in the number of minimally invasive procedures and the increase in cancer incidences in Canada are other factors driving the growth of this market in this region.
Some prominent players in the market include Becton Dickinson and Company (U.S), C.R.Bard, Inc. (U.S.), and Smiths Medical, Inc. (U.K.). Other players include Teleflex Incorporated (U.S.) B Braun Melsungen Ag (Germany), AngioDynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodimed (France).
Browse Related Reports
Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral, Radial) & Procedure (Interventional Cardiology, Radiology) -Global Forecasts to 2022
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets' flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Visit Our Blog@ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets